Advertisement

Topics

Endologix Broadens Recall to All AFX Endovascular AAA Systems

04:29 EDT 16 Oct 2018 | Medscape

The company is recalling all AFX endovascular aortic aneurysm systems after continued problems with type III endoleaks. The FDA has now classified the recall as class I, the most serious designation.
News Alerts

Original Article: Endologix Broadens Recall to All AFX Endovascular AAA Systems

NEXT ARTICLE

More From BioPortfolio on "Endologix Broadens Recall to All AFX Endovascular AAA Systems"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...